昭衍新药
(603127)
| 流通市值：268.66亿 | | | 总市值：320.72亿 |
| 流通股本：6.28亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-09-14 | 1040.90万 | 1.00% | 3964.66万 | 3.80% | 2911.62万 | 2.79% | -7917.18万 | -7.58% |
| 2026-09-11 | -2426.21万 | -2.67% | -7793.29万 | -8.58% | -4100.58万 | -4.51% | 14320.07万 | 15.76% |
| 2026-09-10 | -3635.71万 | -3.79% | -1672.01万 | -1.74% | -60.81万 | -0.06% | 5368.52万 | 5.59% |
| 2026-09-09 | -99.49万 | -0.08% | 2863.61万 | 2.26% | 7943.82万 | 6.26% | -10707.93万 | -8.44% |
| 2026-09-08 | 1784.93万 | 1.15% | 5232.05万 | 3.36% | 12840.29万 | 8.24% | -19857.27万 | -12.75% |
| 2026-09-07 | -3228.00万 | -4.33% | 374.56万 | 0.50% | 5489.35万 | 7.36% | -2635.91万 | -3.53% |
| 2026-09-04 | -7222.69万 | -6.09% | -7528.70万 | -6.35% | 1799.81万 | 1.52% | 12951.57万 | 10.92% |
| 2026-09-03 | -1056.52万 | -0.91% | -1253.11万 | -1.08% | 94.41万 | 0.08% | 2215.22万 | 1.91% |
| 2026-09-02 | 2230.05万 | 1.73% | 2760.34万 | 2.15% | -3332.26万 | -2.59% | -1658.13万 | -1.29% |
| 2026-09-01 | -300.12万 | -0.20% | -12665.17万 | -8.43% | -765.19万 | -0.51% | 13730.48万 | 9.13% |